cGxP.wire https://validator.w3.org/feed/docs/rss2.html Rapport Presents Phase 2 Data for Epilepsy Drug RAP-219 Co-Diagnostics Expands GMP Facility in Saudi Arabia Kama Ayurveda Launches Sandanya Anti-Blemish Range Relay Therapeutics Advances Zovegalisib Clinical Data FDA Investigates E. coli Outbreak Linked to Raw Cheese GC Biopharma Enhances IVIG Safety with FXI Detection USDA FSIS Updates Food Safety Policies and Sampling Data Concept Medical Reports SirPAD Trial Success in PAD restor3d Launches Aeros Modular Stem Ankle System Henlius Secures NMPA IND for HLX319 Breast Cancer Drug CU Anschutz Secures FDA IND for CAR T-Cell Therapy CanWell Pharma Secures FDA IND for CAN016 ADC Trial Allevion Medical Gains FDA 510(k) for Vantage System Vedanta Biosciences Advances VE303 Phase 3 Trial in CDI Denali Therapeutics Regains DNL593 Rights for FTD Quantum BioPharma Submits IND for Lucid-MS Trial InnoCan Secures FDA CVM Waiver for LPT-CBD Drug MiNK Therapeutics Highlights Phase II iNKT Therapy at AACR Trialt and Viedoc Advance Digital Clinical Trial Efficiency Earendil Labs Advances HXN-1001 Into Phase IIa Trial Agenus Showcases Phase II Cancer Immunotherapy Data at AACR Regeneron Wins FDA Nod for EYLEA HD Extended Dosing Regeneron Partners with TriNetX for 300M Patient Data Merck Launches Phase 2b/3 Trial for AMD Eye Therapy Ultragenyx Advances UX016 Into Clinical Trials for GNEM AvenCell Therapeutics Advances Next-Gen CAR-T Therapy Glycomine Advances GLM101 Into Phase 2b Rare Disease Trial Hoth HT-001 Meets Endpoint, Expands Phase 2 Trial in EU Triple Hair Group Advances TH07 Into Phase III Trial Ocugen Completes Dosing in Phase 2/3 Stargardt Trial AstraZeneca Reports Imfinzi Combo Success in Liver Cancer Cipla Wins FDA Approval for IPF Drug Nintedanib Axsome Acquires Balipodect to Expand CNS Drug Pipeline Ultragenyx Advances UX111 Gene Therapy Toward Approval Revolution Medicines Advances Daraxonrasib Into Phase 3 Cogent Biosciences Files NDA for Bezuclastinib in GIST Merck Wins EU Approval for KEYTRUDA Combo in Ovarian Cancer Deupirfenidone Shows Strong IPF Results in Phase 2b Study Panoramic Launches Cardio-Renal Clinical Research Institute Thermo Fisher Launches Compleo System for Cell Therapy Caris Launches ChromoSeq for Myeloid Cancer Profiling BioXcel IGALMI sNDA Accepted by FDA for At-Home Use JenaValve Launches Trilogy Valve for Aortic Regurgitation Merck Partners Infinimmune in $838M Antibody Discovery Deal Samsung Biologics Acquires GSK U.S. Manufacturing Site Ambrosia Biosciences Raises $100M for GLP-1 Pipeline Johnson & Johnson INLEXZO Gets J-Code for Cancer Access Pasithea Wins FDA Fast Track for PAS-004 Cancer Drug GSK Wins China Approval for Exdensur in Severe Asthma Intelligent Bio Advances FDA 510(k) Drug Test Program